Accelerate Diagnostics, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00430H102 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Indaba Capital Management, L.P. 13D/A	9.9%	2,751,762	13D/A	2/6/2025 Event 2/4/2025
Indaba Capital Management, L.P.	9.9%	2,751,762
Ic GP, LLC	9.9%	2,751,762
Derek C. Schrier	9.9%	2,751,762

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q2	1	325 k	$2.08 k	$0
2025 Q1	1	325 k	$228 k	$0
2024 Q4	2	650 k	$781 k	$0
2024 Q3	2	650 k	$1.11 M	$0
2024 Q2	2	650 k	$761 k	$0
2024 Q1	2	650 k	$644 k	$0
2023 Q4	3	519 k	$2.04 M	$0
2023 Q3	3	518 k	$2.98 M	$0
2023 Q2	54	22.5 M	$18.2 M	$9.88 k
2023 Q1	74	25.1 M	$17.6 M	$19.6 k
2022 Q4	79	26.2 M	$18.5 M	$132 k
2022 Q3	93	27.6 M	$41.9 M	$762 k
2022 Q2	81	19.3 M	$19.2 M	$858 k
2022 Q1	115	24.4 M	$35.7 M	$247 k
2021 Q4	117	25.0 M	$130 M	$1.88 M
2021 Q3	110	23.6 M	$138 M	$1.11 M
2021 Q2	104	25.8 M	$208 M	$1.94 M
2021 Q1	112	24.7 M	$205 M	$3.03 M
2020 Q4	127	28.2 M	$214 M	$2.92 M
2020 Q3	124	29.2 M	$311 M	$3.33 M
2020 Q2	140	31.5 M	$477 M	$9.61 M
2020 Q1	124	31.7 M	$265 M	$3.47 M
2019 Q4	126	33.1 M	$559 M	$12.9 M
2019 Q3	128	31.5 M	$585 M	$13.6 M
2019 Q2	143	32.2 M	$736 M	$34.5 M
2019 Q1	136	27.6 M	$580 M	$24.5 M
2018 Q4	127	28.1 M	$330 M	$13.9 M
2018 Q3	140	26.8 M	$616 M	$35.0 M
2018 Q2	134	24.8 M	$553 M	$32.1 M
2018 Q1	132	21.4 M	$490 M	$19.6 M
2017 Q4	132	20.7 M	$544 M	$27.1 M
2017 Q3	132	22.2 M	$499 M	$15.9 M
2017 Q2	131	20.2 M	$554 M	$15.6 M
2017 Q1	109	20.8 M	$505 M	$6.96 M
2016 Q4	118	15.4 M	$320 M	$5.06 M
2016 Q3	113	14.5 M	$396 M	$5.87 M
2016 Q2	101	13.6 M	$196 M	$2.21 M
2016 Q1	98	13.8 M	$198 M	$1.20 M
2015 Q4	101	13.6 M	$292 M	$4.69 M
2015 Q3	91	10.4 M	$168 M	$1.63 M
2015 Q2	87	10.1 M	$260 M	$1.88 M
2015 Q1	77	8.67 M	$195 M	$2.54 M
2014 Q4	82	7.90 M	$152 M	$1.40 M
2014 Q3	77	5.39 M	$116 M	$4.54 M
2014 Q2	82	4.91 M	$128 M	$8.92 M
2014 Q1	59	8.87 M	$193 M	$4.38 M